S. 3751
119th Congress
Senate
Prescription Drug Supply Chain Pricing Transparency Act
Official title: A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 29, 2026
Read twice and referred to the Committee on Finance.
Jan 29, 2026
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Read twice and referred to the Committee on Finance.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
2
Bodies those filers lobbied
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 3751: Prescription Drug Supply Chain Pricing Transparency Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-3751/
"S. 3751: Prescription Drug Supply Chain Pricing Transparency Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-3751/.
S. 3751, 119th Cong. (2026), https://openamerica.io/bill/119-S-3751/.
[S. 3751: Prescription Drug Supply Chain Pricing Transparency Act](https://openamerica.io/bill/119-S-3751/)